RxDoctor Payments Data

Alisa Ward

Obstetrics & Gynecology · Frisco, TXNPI 1437207800

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.4% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 44.5% of the total. Reporting peaked in 2023 at $312 and has fallen 73.4% since, to $83 in 2025.

$1,589in general payments, 2019–2025

Across 97 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$706
  • Pfizer$174
  • Millicent US Inc$85
  • Astellas Pharma US Inc$61
  • Avion Pharmaceuticals$60
  • Therapeuticsmd, Inc.$60
  • plus $442 from 19 others

What the payments were for

  • Food & beverage$1,54797%
  • Education$423%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,589 in reported general payments places this provider in the 60th percentile of 3,099 obstetrics & gynecology providers in Texas.

See all obstetrics & gynecology providers in Texas →

Other obstetrics & gynecology in Frisco

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →